S&P/ASX 200 Index (ASX: XJO) shares are down 1.3% at 8,925.3 points at the time of writing on Friday.
The market is taking a breather after a strong week that saw the ASX 200 lift to a 14-week high of 9,043.5 points.
Earnings season is well underway, with strong results from several majors pushing the ASX 200 3.84% higher by Thursday’s close.
On Wednesday, Commonwealth Bank of Australia (ASX: CBA) surprised the market with a 6% cash profit lift for 1H FY26.
That saw CBA shares snatch the crown as the largest ASX 200 stock by market cap back from BHP Group Ltd (ASX: BHP) on Thursday.
CBA declared a fully-franked interim dividend of $2.35 per share, up 4% from 1H FY25, with the ex-dividend date next Wednesday.
Check out other ASX 200 shares going ex-dividend next week here.
ANZ Group Holdings Ltd (ASX: ANZ) also surprised with a $1.94 billion cash profit in 1Q FY26, up 75% on the 2H FY25 quarterly average.
That news sent ANZ shares to a record high of $40.95 today.
Northern Star Resources Ltd (ASX: NST) also impressed with a 41% lift in statutory profit to $714.4 million for 1H FY26.
Northern Star will pay a fully-franked interim dividend of 25 cents per share.
The positive result sent the largest gold miner on the ASX 200 to a record high of $30.21 per share yesterday.
While some ASX 200 shares are hitting record highs, many are skirting new lows this week.
ASX 200 shares at 52-week lows on Friday
Scores of ASX 200 shares are hitting multi-year lows today.
Here is a sample of them.
JB HiâFi Ltd (ASX: JBH)
The JB HiâFi Ltd share price fell 3.9% to an 18-month low of $76.34 on Friday.
The popular retailer is due to release its earnings report on Monday, according to our calendar.
Temple & Webster Group Ltd (ASX: TPW)
Temple & Webster shares dipped 5.2% to a two-year low of $7.24.
This ASX 200 retail share got smashed this week after dropping its 1H FY26 report.
Cochlear Ltd (ASX: COH)
The Cochlear share price has disintegrated on Friday after the release of the company’s 1H FY26 results.
The ASX 200 healthcare share nosedived 17.8% to a two-and-a-half-year low of $202.21.
Xero Ltd (ASX: XRO)
The Xero share price tumbled 5.4% to a three-year low of $72.26 on Friday.
Tech shares are having a rough trot, particularly those in the software-as-a-service (SaaS) space, due to fears that AI will replace them.
The S&P/ASX 200 Information Technology Index (ASX: XIJ) is down 24% in the year to date.
Pro Medicus Ltd (ASX: PME)
Pro Medicus shares dived 8.3% to a two-and-a-half-year low of $118.23 on Friday.
Investors thrashed this ASX 200 healthcare share despite the company reporting record results this week.
Aristocrat Leisure Ltd (ASX: ALL)
Aristocrat Leisure shares dipped 4.9% to an 18-month low of $48.48 on Friday.
WiseTech Global Ltd (ASX: WTC)
Today, the WiseTech share price tanked 14.7% to a three-and-a-half-year low of $40.59.
Wisetech will release its earnings report on Wednesday.
Technology One Ltd (ASX: TNE)
TechnologyOne shares dropped 7.1% to an 18-month low of $20.17 today.
Telix Pharmaceuticals Ltd (ASX: TLX)
The Telix Pharmaceuticals share price fell 2.8% to a two-year low of $8.83.
Guzman y Gomez (ASX: GYG)
Guzman y Gomez shares dropped 8.7% to a record low of $18.58 on Friday.
Mirvac Group (ASX: MGR)
The Mirvac Group share price fell 1.6% to a 52-week low of $1.90.
The ASX 200 property share will be on watch next Wednesday when the company releases its earnings report.
Dexus (ASX: DXS)
This ASX 200 REIT share fell 2.5% to a 52-week low of $6.16 on Friday.
Objective Corporation Ltd (ASX: OCL)
The Objective Corporation share price fell 4% to a two-year low of $12.88 today.
The post 13 ASX 200 shares hit multi-year lows as the market takes a breather appeared first on The Motley Fool Australia.
Should you invest $1,000 in Aristocrat Leisure Limited right now?
Before you buy Aristocrat Leisure Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Aristocrat Leisure Limited wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 Jan 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Why Austal, Cochlear, Nick Scali, and WiseTech shares are tumbling today
- Everything you need to know about the latest Cochlear dividend
- Cochlear shares sink 17% on results day
- Cochlear posts modest sales growth but lower profit as Nexa launch continues
- Are Temple & Webster shares a buy after falling 32% yesterday following earnings results?
Motley Fool contributor Bronwyn Allen has positions in BHP Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear, Objective, Technology One, Telix Pharmaceuticals, Temple & Webster Group, WiseTech Global, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Objective, WiseTech Global, and Xero. The Motley Fool Australia has recommended BHP Group, Cochlear, Pro Medicus, Technology One, Telix Pharmaceuticals, and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.